Page last updated: 2024-11-06

triethylenemelamine and Rhabdomyosarcoma

triethylenemelamine has been researched along with Rhabdomyosarcoma in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FEIND, CR1
HERTER, F1
MARKOWITZ, A1
Lawhorn, TI1
Stone, HH1
Martin, JD1

Reviews

1 review available for triethylenemelamine and Rhabdomyosarcoma

ArticleYear
Chemotherapy in solid tumors of childhood.
    Oncology, 1972, Volume: 26, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla

1972

Other Studies

1 other study available for triethylenemelamine and Rhabdomyosarcoma

ArticleYear
IMPROVEMENTS IN ISOLATION HEAD PERFUSION.
    American journal of surgery, 1963, Volume: 106

    Topics: Carcinoma, Squamous Cell; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Child; Chordom

1963